Arkema's latest narrative update comes with a slightly lower fair value of €65.06, alongside a marginally reduced discount rate of 8.87% and a fractional trim to long term revenue growth assumptions to 1.85% per year. These adjustments reflect a more cautious balance between cyclical headwinds and optimism around Arkema's shift toward higher value specialty materials, as analysts recalibrate expectations without abandoning the longer term story. Read on to see how you can stay ahead of these evolving assumptions and keep track of how the Arkema narrative continues to shift over time.

Analyst Price Targets don't always capture the full story. Head over to our Company Report to find new ways to value Arkema.

???? Bullish Takeaways

Citi, Deutsche Bank and Berenberg all maintain Buy ratings, signaling that a core group of analysts still see Arkema as a structurally attractive specialty chemicals name despite recent macro and sector headwinds.

Deutsche Bank has trimmed its targets in stages, from €80 to €76 and then to €65, and still rates the shares Buy, which implies confidence in Arkema's execution and self help potential even as it embeds more conservative assumptions.

Citi's Ranulf Orr lowered the price target slightly, from €83 to €80, but kept a Buy rating, which suggests the firm continues to reward Arkema's strategy and growth prospects while acknowledging a softer near term environment.

Berenberg's Sebastian Bray cut the target from €75 to €58 and kept a Buy rating, highlighting that, in the firm's view, recent pressure is largely reflected in the share price, with valuation leaving room for potential upside if Arkema delivers on its plan.

???? Bearish Takeaways

Barclays downgraded Arkema to Underweight with a €47 target, reflecting a more negative stance on European diversified chemicals and signaling that, in its view, sector and cyclical risks could weigh on the multiple and constrain potential upside.

JPMorgan cut its target from €65 to €55 and remains Neutral, which underscores concerns around near term conditions and suggests that, at current levels, much of the medium term improvement story may already be priced in.

Taken together, the lower targets from Berenberg, Deutsche Bank, Citi, JPMorgan and Barclays indicate a broad repricing of expectations, with bears focused on cyclical headwinds and valuation risk even as some peers still back Arkema's longer term growth trajectory.

Do your thoughts align with the Bull or Bear Analysts? Perhaps you think there's more to the story. Head to the Simply Wall St Community to discover more perspectives or begin writing your own Narrative!

Arkema signed a strategic MoU with Semcorp to co develop next generation battery separator technologies, supporting Semcorp's global expansion in EVs, energy storage, and consumer electronics.

The company obtained ISCC PLUS certification for waterborne acrylic resins at its Boretto, Italy site, enabling up to 100% Product Carbon Footprint reduction and broadening its range of mass balance, bio attributed coating solutions.

Arkema further advanced its global Mass Balance roadmap by adding Boretto to its certified waterborne resin facilities in Saint Charles (US), Zwickau (Germany), and Changshu (China), extending coverage across a wide portfolio of specialty resins and additives.

A €40 million modernization and decarbonization project at the Lacq/Mourenx sulfur derivatives site was completed. This project cut SO2 emissions by 40%, reduced GHG emissions by over 10%, lowered water consumption, and generated sulfuric acid for reuse in other industrial processes under the France 2030 framework.

Fair Value: Trimmed slightly from €66.06 to €65.06, reflecting modestly softer long term assumptions.

Discount Rate: Edged down marginally from 8.90% to about 8.87%, implying a slightly lower perceived risk profile.

Revenue Growth: Reduced fractionally from roughly 1.86% to 1.85% per year, indicating a very small downgrade to top line expectations.

Net Profit Margin: Lowered slightly from about 4.54% to 4.46%, incorporating a mild decrease in projected profitability.

Future P/E: Nudged higher from 13.47x to about 13.52x, suggesting a marginally richer multiple on updated earnings forecasts.

Narratives are a simple way to connect the story you believe about a company with hard numbers like future revenue, earnings, margins, and fair value. On Simply Wall St's Community page, used by millions of investors, a Narrative links Arkema's strategy and risks to a financial forecast and a fair value, then compares that to the current share price to help inform investment decisions. As news, earnings, or guidance change, the Narrative and its valuation update dynamically so you always see the latest view.

Head over to the Simply Wall St Community and follow the Narrative on Arkema to stay up to date on:

How new sustainability and decarbonization projects could support a future rerating and improve Arkema's long term margin profile.

Whether investments in biobased polyamides, PVDF, and specialty additives translate into faster revenue growth and a higher fair value than today.

How macro headwinds, competition, FX moves, and leverage risks might derail the current earnings path and change the risk reward trade off.

Read the full Arkema Narrative and track every update in real time.

Curious how numbers become stories that shape markets? Explore Community Narratives

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include AKE.PA.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com